header photo

Joel Lavine

Professor of Pediatrics (tenured) Columbia University

About Me

Jel Lavine, MD, has had a lengthy career filled with several achievements that illustrate his abilities and significance in his area. He has primarily concentrated on clinical research, clinical treatment, teaching, and program management as an academic physician-scientist. Understanding his continuous career may act as motivation for persons of all ages who are seeking to get into this industry.

Joel Lavine's work has centered on a variety of topics, including finding and understanding underlying biological processes and disorders that impact children and need the application of basic science, engineering, computers, and diagnostic instruments to properly address. His study spans a wide variety of domains, allowing him to be a trailblazer in a surprising number of areas.

For example, throughout the past two decades, he has worked to combine pediatrics, internal medicine, pathology, and radiology together to assist children and adults with obesity. Identifying different treatment strategies that may assist obese individuals better understand their body and the influence that obesity has on them is one of these subjects. This study spans just 20 years of his illustrious and illustrious career.

Natural history, genetics, biomarker creation, and therapy of nonalcoholic fatty liver disease, or NAFLD, are among his key research interests. Few individuals realize how serious this ailment is and how harmful it is to the body. Around 25% of all individuals in the United States have this disorder, which may lead to cirrhosis, liver cancer, and other problems.

Throughout his career, Joel Lavine has been involved in several research initiatives that have helped to identify contributing variables and therapies for NAFLD and other related illnesses. For example, he was one of eight Principal Investigators and the sole Pediatric Investigator who helped develop and serve on the NASH Clinical Research Network at the National Institutes of Diabetes, Kidney, and Digestive Diseases (NIDDK). He served as the committee's co-chair for 16 years and was instrumental in the development of all but one of the protocols used in pediatric health research.